Emerging Growth Capital Investors offers retail and wholesale investors access to a fund of Australian small cap listed biotechnology and life science companies.
The Your Future, Your Super performance test is inhibiting the use of alternative investments and will continue to do so as long as it poses an elevated risk to superannuation funds, but a panel of experts believe the industry is too smart and too creative not to readjust and find a way for the asset class to be included in portfolios.
Tahn SharpeSeptember 21, 2021
